These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 10873065

  • 1. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
    Huang SM, Harari PM.
    Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).
    Huang SM, Li J, Armstrong EA, Harari PM.
    Cancer Res; 2002 Aug 01; 62(15):4300-6. PubMed ID: 12154033
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec 01; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep 01; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 6. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM.
    Cancer Res; 2004 Aug 01; 64(15):5355-62. PubMed ID: 15289342
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
    Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM, Harari PM.
    Cancer Res; 2005 Apr 15; 65(8):3328-35. PubMed ID: 15833866
    [Abstract] [Full Text] [Related]

  • 8. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
    Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP.
    Clin Cancer Res; 1999 Feb 15; 5(2):257-65. PubMed ID: 10037173
    [Abstract] [Full Text] [Related]

  • 9. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
    Viloria-Petit A, Crombet T, Jothy S, Hicklin D, Bohlen P, Schlaeppi JM, Rak J, Kerbel RS.
    Cancer Res; 2001 Jul 01; 61(13):5090-101. PubMed ID: 11431346
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR, Tortora G.
    Clin Cancer Res; 1999 Apr 01; 5(4):909-16. PubMed ID: 10213228
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
    Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.
    Clin Cancer Res; 2002 May 01; 8(5):1253-64. PubMed ID: 12006546
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C, Bianco R, Tortora G, Damiano V, Guerrieri P, Montemaggi P, Mendelsohn J, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2000 Nov 01; 6(11):4343-50. PubMed ID: 11106252
    [Abstract] [Full Text] [Related]

  • 13. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.
    Clin Cancer Res; 1998 Dec 01; 4(12):2957-66. PubMed ID: 9865906
    [Abstract] [Full Text] [Related]

  • 14. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
    Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J, Fan Z.
    Clin Cancer Res; 2000 Feb 01; 6(2):701-8. PubMed ID: 10690556
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
    Milas L, Fan Z, Andratschke NH, Ang KK.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):966-71. PubMed ID: 14967457
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
    Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ, Slamon DJ.
    Cancer Res; 1999 Mar 15; 59(6):1347-55. PubMed ID: 10096569
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V, Lahusen T, Leethanakul C, Igishi T, Kremer M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS, Senderowicz AM.
    Clin Cancer Res; 2002 Nov 15; 8(11):3549-60. PubMed ID: 12429646
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.
    Huang SM, Bock JM, Harari PM.
    Cancer Res; 1999 Apr 15; 59(8):1935-40. PubMed ID: 10213503
    [Abstract] [Full Text] [Related]

  • 19. Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade.
    Huang SM, Li J, Harari PM.
    Mol Cancer Ther; 2002 May 15; 1(7):507-14. PubMed ID: 12479268
    [Abstract] [Full Text] [Related]

  • 20. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR.
    Cancer Res; 1999 Jul 15; 59(14):3374-8. PubMed ID: 10416597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.